What treatment
Explore Life-Changing Success Stories in China
Join the Thousands Who Benefited from in China
Trusted Medical Tourism Platform Since 2007
Fighting Relapsed DLBCL with Dual CAR-T Therapy
David, a 59-year-old teacher from Australia, traveled to Beijing, China, after standard chemotherapy failed to control his relapsed Diffuse Large B-Cell Lymphoma (DLBCL). He underwent Dual CD19 & CD20 CAR-T cell therapy, achieving rapid immune cell expansion and encouraging complete response indicators without major complications. Today, he continues his recovery with renewed hope and ongoing medical follow-up....
Read more detailsDiscover your treatment options with a free, no-obligation quote!
Get your quote now!Discover your treatment options with a free, no-obligation quote!
Get your quote now!